Achieve Life Sciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2024 | 1 | -$0.27 | -$0.27 | -$0.27 |
| Q3 2024 | 3 | -$0.44 | -$0.23 | -$0.34 |
| Q1 2025 | 3 | -$0.40 | -$0.31 | -$0.36 |
| Q2 2025 | 2 | -$0.33 | -$0.33 | -$0.33 |
| Q3 2025 | 2 | -$0.30 | -$0.30 | -$0.30 |
| Q4 2025 | 2 | -$0.32 | -$0.32 | -$0.32 |
Achieve Life Sciences, Inc. Earnings Date And Information
Achieve Life Sciences, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.36 earnings per share for the quarter, missing analysts' consensus estimates of $-0.26 by $0.1. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Achieve Life Sciences, Inc. has generated $-2 earnings per share over the last year ($-1.5 diluted earnings per share) and currently has a price-to-earnings ratio of -4.34. Achieve Life Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
Achieve Life Sciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.26 | -$0.36 | -0.1 | $0 | $0 |
| 08/13/2024 | Q2 2024 | -$0.22 | -$0.25 | -0.03 | $0 | $0 |
| 05/09/2024 | Q1 2024 | -$0.24 | -$0.26 | -0.02 | $0 | |
| 12/29/2023 | Q4 2023 | -$0.26 | $0 | |||
| 11/09/2023 | Q3 2023 | -$0.34 | -$0.34 | 0 | $0 | |
| 08/14/2023 | Q2 2023 | -$0.41 | -$0.43 | -0.02 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.65 | -$0.53 | 0.12 | $0 | |
| 05/16/2023 | Q4 2022 | -$0.81 | $0 | |||
| 11/14/2022 | Q3 2022 | -$1.10 | -$1.40 | -0.3 | $62,500 | $0 |
| 08/11/2022 | Q2 2022 | -$0.79 | -$1.13 | -0.34 | $62,500 | $0 |
| 05/12/2022 | Q1 2022 | -$0.82 | -$0.84 | -0.02 | $0 | |
| 03/10/2022 | Q4 2021 | -$0.73 | -$0.76 | -0.03 | $0 | |
| 11/09/2021 | Q3 2021 | -$1.09 | -$0.71 | 0.38 | $0 | |
| 08/12/2021 | Q2 2021 | -$1.53 | $0 | |||
| 05/13/2021 | Q1 2021 | -$0.78 | -$1.30 | -0.52 | $0 | |
| 03/11/2021 | Q4 2020 | -$1.27 | -$0.77 | 0.5 | $0 | |
| 11/12/2020 | Q3 2020 | -$1.30 | -$1.14 | 0.16 | $0 | |
| 08/06/2020 | Q2 2020 | -$3.80 | -$1.68 | 2.12 | $0 | |
| 05/14/2020 | Q1 2020 | -$2.40 | -$2.15 | 0.25 | $0 | |
| 03/13/2020 | Q4 2019 | -$5.40 | -$5.91 | -0.51 | $0 |
Achieve Life Sciences, Inc. Earnings: Frequently Asked Questions
-
When is Achieve Life Sciences, Inc.'s earnings date?
Achieve Life Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
-
How can I listen to Achieve Life Sciences, Inc.'s earnings conference call?
The conference call for Achieve Life Sciences, Inc.'s latest earnings report can be listened to online.
-
How can I read Achieve Life Sciences, Inc.'s conference call transcript?
The conference call transcript for Achieve Life Sciences, Inc.'s latest earnings report can be read online.
-
How much profit does Achieve Life Sciences, Inc. generate each year?
Achieve Life Sciences, Inc. (:ACHV) has a recorded net income of $0. Achieve Life Sciences, Inc. has generated $-1.5 earnings per share over the last four quarters.
-
What is Achieve Life Sciences, Inc.'s price-to-earnings ratio?
Achieve Life Sciences, Inc. (:ACHV) has a price-to-earnings ratio of -4.34 and price/earnings-to-growth ratio is -0.14.
